These results demonstrate that GLP-1 may preferentially alleviate dysregulated glucose uptake and glycogen metabolism in skeletal muscle in the context of obesity by rescuing deficits in AKT/PI3K signaling, but not in conditions of T2DM or normal physiology. The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.